Michael K Jones
Overview
Explore the profile of Michael K Jones including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
700
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kent A, Gil K, Jones M, Linden B, Purev E, Haverkos B, et al.
Transplant Cell Ther
. 2024 Aug;
PMID: 39154914
Despite the concurrent use of haploidentical cord (HCT) and dual cord (DCT) stem cell transplant approaches for over a decade, there have been few comparisons of their outcomes. Our objective...
2.
Jones M, Gupta K, Peters T, Beardsley J, Jackson J
MedEdPORTAL
. 2022 May;
18:11242.
PMID: 35539004
Introduction: Pharmacology is an important learning topic in preclinical medical education. Simulated patient encounters allow students to apply basic science knowledge in a clinical setting and have been useful in...
3.
Mendiratta G, Jones M, Stites E
Mol Cell Oncol
. 2022 May;
9(1):2065176.
PMID: 35529901
Genome sequenced samples from cancer patients helped identify roles of different mutation types and enabled targeted therapy development. However, critical questions like what are the gene mutation rates among the...
4.
Jones M, OConnell N, Skelton J, Halvorson E
J Healthc Qual
. 2022 Mar;
44(4):230-239.
PMID: 35302524
Objectives: Missed appointments negatively affect patients, providers, and health systems. This study aimed to (1) quantify the percentage of missed appointments across 14 pediatric subspecialties in a tertiary-care children's hospital...
5.
Ahluwalia A, Patel K, Hoa N, Brzozowska I, Jones M, Tarnawski A
Am J Physiol Gastrointest Liver Physiol
. 2021 Oct;
321(6):G682-G689.
PMID: 34668398
Tissue injury healing is impaired in aging, and this impairment is caused in part by reduced angiogenesis. Melatonin, a neuroendocrine hormone that regulates sleep and circadian rhythm, is also produced...
6.
Lei J, Paul J, Wang Y, Gupta M, Vang D, Thompson S, et al.
Antioxid Redox Signal
. 2020 Jul;
34(4):279-293.
PMID: 32729340
Lifelong pain is a hallmark feature of sickle cell disease (SCD). How sickle pathobiology evokes pain remains unknown. We hypothesize that increased cell-free heme due to ongoing hemolysis activates toll-like...
7.
Ahluwalia A, Hoa N, Jones M, Tarnawski A
Am J Physiol Gastrointest Liver Physiol
. 2019 Sep;
317(6):G862-G871.
PMID: 31545918
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as diclofenac (DFN) and indomethacin (INDO) are extensively used worldwide. Their main side effects are injury of the gastrointestinal tract, including erosions, ulcers, and bleeding....
8.
Jones M, Nair A, Gupta M
Front Cell Neurosci
. 2019 May;
13:171.
PMID: 31133804
Neurodegenerative diseases affect millions of people worldwide, yet there are currently no effective treatments. Because risk of neurodegenerative disease substantially increases with age, greater life expectancy with a concomitant aging...
9.
Aich A, Jones M, Gupta K
Curr Opin Hematol
. 2019 Mar;
26(3):131-138.
PMID: 30893088
Purpose Of Review: Pain is a major comorbidity of sickle cell disease (SCD). Opioids are the mainstay for pain treatment but remain suboptimal. We discuss mechanism-based treatable targets devoid of...
10.
Ahluwalia A, Jones M, Hoa N, Tarnawski A
J Cell Biochem
. 2019 Feb;
120(7):11651-11659.
PMID: 30790334
Gastric epithelial cells are important components of mucosal protection and targets of nonsteroidal anti-inflammatory drugs (NSAIDs)-induced injury. Diclofenac (DFN) is one of the most widely used NSAIDs; however, even its...